The Medicines and Healthcare products Regulatory Agency (MHRA), acting jointly with the Department of Health in Northern Ireland, have launched a UK-wide consultation on proposals to amend the Human Medicines Regulations 2012 (HMRs), to allow...
The Department of Health values the views of stakeholders and recognises the important role they play in shaping our work. We are committed to engaging with individuals and organisations who have an interest in our...
Public Consultation on the The control of Gamma-Butyrolactone
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. Guidance is locally reviewed for applicability to Northern Ireland and, where appropriate, is endorsed for...
The Food Standards Agency in Northern Ireland and the Department of Health have launched a public consultation seeking views on proposals to introduce restrictions on the promotion and placement of products high in fat, sugar...
This consultation is seeking your views on proposals aimed at reviewing the prescribing of selected medicines, which Departmental guidance considers having low and limited clinical value, from General Practitioner (GP) practices in primary care in...
The Department has today launched a consultation targeted at key stakeholders including registered community pharmacists, community pharmacy owners and pharmacy representative bodies seeking views on potential amendments to the terms of service for chemists as...
This consultation seeks views on reimbursement arrangements under The Healthy Start Scheme and Day Care Food Scheme Regulations (Northern Ireland) 2006. The Department of Health values all views, however feedback from Day Care Providers is...
The Department has today launched a consultation targeted at key stakeholders including community pharmacies, and pharmacy representative bodies seeking views on several options for increasing pharmacy Premises Fees which have not been increased since 2011.
The Medicines and Healthcare products Regulatory Agency (MHRA) is leading on proposed changes to how gene therapies are defined in UK-wide medicines legislation. The proposed amendments would make regulatory oversight more consistent by ensuring that...
Summary NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. Guidance is locally reviewed for applicability to Northern Ireland and, where appropriate, is endorsed...
On 6 January 2026 the Finance Minister published a Draft Budget setting out for each Northern Ireland department his proposals for Resource expenditure allocations for the period April 2026 to March 2029 and Capital investment...
The Secretary of State for Health and Social Care, in relation to England and Wales and Scotland, and in conjunction with the Department of Health NI in relation to Northern Ireland (pursuant to Section 45(1)...